However, these data we now report add to an increasing number of independent studies reporting clinical associations between gastrointestinal tumour expression of MRP2 and non-responsiveness to chemotherapy with oxaliplatin or cisplatin23,32–35. The gene discussed is ABCC2; the disease is digestive system neoplasm.